We are live on ! Find out more
SQZ

SQZ Biotechnologies Company

Delisted

SQZ was delisted on the 3rd of July, 2023.

0 hedge funds and large institutions have $0 invested in SQZ Biotechnologies Company in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 50 (-5)

100% less capital invested

Capital invested by funds: $333K → $0 (-$333K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
Holders Change
-5
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AIG
1
American International Group
New York
-$202K -2,517,173 Closed
AG
2
Artal Group
Luxembourg
-$129K -1,606,309 Closed
BSB
3
Bangor Savings Bank
Maine
-$911 -11,357 Closed
BTI
4
Blue Trust Inc
Georgia
-$1K -4,195 Closed
Barclays
5
Barclays
United Kingdom
-$144 -1,794 Closed

SQZ Hedge Fund Activity: Q4 2023 in Review

0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q4 2023, worth a combined $0 — down 100% from $333K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of SQZ and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was American International Group, exiting entirely with an estimated $202K sold.

  • 0 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q4 2023, down from 5 in Q3 2023.
  • Funds reported $0 of SQZ Biotechnologies Company stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new SQZ Biotechnologies Company positions in Q4 2023 and 5 closed out, a net change of -5 holders.
  • The largest SQZ Biotechnologies Company seller in Q4 2023 was American International Group, an estimated $202K sold.

Based on aggregated 13F filings for Q4 2023.